UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050198
Receipt number R000057160
Scientific Title Attachment formation study of ASD by animal robots
Date of disclosure of the study information 2023/01/31
Last modified on 2023/08/31 09:48:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory research on the possibility of attachment formation in infants with autism spectrum disorder using an animal robot (new type aibo)

Acronym

Attachment formation study of ASD by animal robots

Scientific Title

Attachment formation study of ASD by animal robots

Scientific Title:Acronym

Attachment formation study of ASD by animal robots

Region

Japan


Condition

Condition

autistic spectrum disorder

Classification by specialty

Pediatrics Psychiatry Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Attachment potential

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Differences in contact and play with aibo between high ASD trait group and low ASD trait group

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

High ASD group play with animal robots for 10 minutes

Interventions/Control_2

Low ASD group play with animal robots for 10 minutes

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

4 years-old <=

Age-upper limit

8 years-old >=

Gender

Male and Female

Key inclusion criteria


HighASD
Children between the ages of 4 and 8
FIQ 70 or higher in the intelligence test Tanaka Binet or WISC .
Children diagnosed with autism spectrum disorder according to the American Medical Association diagnostic criteria DSM5
A score of 20 or higher on the Autism Spectrum Disorder Scale AQJ Children's Edition
Children who have obtained written consent from their legal representatives and have obtained consent to participate in this study from the subject himself/herself
Children who applied at a university hospital

LowASD
Children between the ages of 4 and 8
FIQ 70 or higher in the intelligence test Tanaka Binet or WISC.
Children diagnosed with autism spectrum disorder according to the American Medical Association diagnostic criteria DSM 5
Autism Spectrum Disorder Scale of AQJ Children's version of 19 points or less
Children who have obtained written consent from their legal representatives and have obtained consent to participate in this study from the subject
Children who applied at a university hospital

Key exclusion criteria

Infants judged inappropriate by the attending physician

Target sample size

20


Research contact person

Name of lead principal investigator

1st name kazuya
Middle name
Last name ono

Organization

St Marianna University of Medicine

Division name

Neuropsychiatry

Zip code

216-8511

Address

2-16-1 sugao miyamae-ku kawasaki city kanagawa

TEL

044-977-8111

Email

kazuya.ono@marianna-u.ac.jp


Public contact

Name of contact person

1st name kazuya
Middle name
Last name ono

Organization

St Marianna University of Medicine

Division name

Neuropsychiatry

Zip code

216-8511

Address

2-16-1 sugao miyamae-ku kawasaki city kanagawa

TEL

044-977-8111

Homepage URL


Email

kazuya.ono@marianna-u.ac.jp


Sponsor or person

Institute

St Marianna University of Medicine

Institute

Department

Personal name

kazuya ono


Funding Source

Organization

St Marianna University of Medicin

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

St. Marianna University School of Medicine Bioethics Committee Clinical Trial Subcommittee202

Address

2-16-1 sugao miyamae-ku kawasaki city kanagawa

Tel

044-977-8111

Email

k-sienbu.mail@marianna-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

聖マリアンナ医科大学付属病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 01 Month 31 Day

Date of IRB

2023 Year 04 Month 14 Day

Anticipated trial start date

2023 Year 04 Month 30 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 01 Month 31 Day

Last modified on

2023 Year 08 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057160


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name